Mucins in cancer: function, prognosis and therapy
DW Kufe - Nature Reviews Cancer, 2009 - nature.com
Epithelia are protected from adverse conditions by a mucous barrier. The secreted and
transmembrane mucins that constitute the mucous barrier are largely unrecognized as …
transmembrane mucins that constitute the mucous barrier are largely unrecognized as …
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
DW Kufe - Oncogene, 2013 - nature.com
Abstract Mucin 1 (MUC1) is a heterodimeric protein formed by two subunits that is aberrantly
overexpressed in human breast cancer and other cancers. Historically, much of the early …
overexpressed in human breast cancer and other cancers. Historically, much of the early …
Mucins in pancreatic cancer and its microenvironment
Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic
resistance, frequent recurrence and the absence of treatment strategies that specifically …
resistance, frequent recurrence and the absence of treatment strategies that specifically …
MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1
M Sachdeva, YY Mo - Cancer research, 2010 - AACR
MicroRNAs are important gene regulators that could play a profound role in tumorigenesis.
Our previous studies indicate that miR-145 is a tumor suppressor capable of inhibiting tumor …
Our previous studies indicate that miR-145 is a tumor suppressor capable of inhibiting tumor …
MUC1 and metastatic cancer: expression, function and therapeutic targeting
TM Horm, JA Schroeder - Cell adhesion & migration, 2013 - Taylor & Francis
MUC1 is a transmembrane mucin that is often overexpressed in metastatic cancers and
often used as a diagnostic marker for metastatic progression. The extracellular domain of …
often used as a diagnostic marker for metastatic progression. The extracellular domain of …
Dependence on the MUC1-C oncoprotein in non–small cell lung cancer cells
D Raina, M Kosugi, R Ahmad, G Panchamoorthy… - Molecular cancer …, 2011 - AACR
Non–small cell lung cancer (NSCLC) cells are often associated with constitutive activation of
the phosphoinositide 3-kinase (PI3K)→ Akt→ mTOR pathway. The mucin 1 (MUC1) …
the phosphoinositide 3-kinase (PI3K)→ Akt→ mTOR pathway. The mucin 1 (MUC1) …
Mucin-interacting proteins: from function to therapeutics
Mucins are high molecular weight glycoproteins that are involved in regulating diverse
cellular activities both in normal and pathological conditions. Mucin activity and localization …
cellular activities both in normal and pathological conditions. Mucin activity and localization …
MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
BG Bitler, A Goverdhan… - Journal of cell …, 2010 - journals.biologists.com
Alteration of protein trafficking and localization is associated with several diseases, including
cystic fibrosis, breast cancer, colorectal cancer, leukemia and diabetes. Specifically …
cystic fibrosis, breast cancer, colorectal cancer, leukemia and diabetes. Specifically …
[HTML][HTML] Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma
AE Sirica - World journal of gastroenterology: WJG, 2008 - ncbi.nlm.nih.gov
Aberrant expression and signaling of epidermal growth factor receptor (ErbB) family receptor
tyrosine kinases, most notably that of ErbB2 and ErbB1, have been implicated in the …
tyrosine kinases, most notably that of ErbB2 and ErbB1, have been implicated in the …
[HTML][HTML] The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
The most common ovarian cancer is epithelial ovarian cancer (EOC) characterised by few
early symptoms, widespread peritoneal dissemination and ascites at advanced stages that …
early symptoms, widespread peritoneal dissemination and ascites at advanced stages that …